from Mitchell Report

A middle-aged man with dark hair and glasses sits at a wooden desk in a warmly lit room, looking thoughtfully at a paper he holds with both hands. The paper features a red heart with a white heartbeat line and a green upward trending graph. He wears a blue button-up shirt. On the desk in front of him is an open notebook with handwritten notes and a black pen resting on it. To his right is a tall glass of iced tea with a lime wedge on the rim. To his left, a small potted plant and a framed sign read "Grateful Stronger Moving Forward" with a small red heart at the bottom. Behind him on the wall is a framed picture of a red heart with a heartbeat line and the words "Progress Patience Purpose." A laptop on a side table displays a similar graph. Books titled "The Healing Heart" and "A Path to Wellness" are stacked near the window, through which sunlight filters, casting a warm glow. The overall atmosphere is calm and reflective.

A man reflects with quiet satisfaction as he reviews positive echo results, surrounded by reminders of gratitude, strength, and progress in a warm, sunlit room.

I wanted to share a long-overdue health update about what has happened this year and why I can finally talk about it. I recently had my second Camzyos cardiology echo and doctor’s visit of the year. I normally go every six months, and this visit gave me my best numbers yet.

On Camzyos, my obstruction is much better controlled. My echo looked fantastic, so I included a table below comparing my results before and after starting Camzyos.

When I first started Camzyos, I was not getting my refills consistently because of REMS requirements and the timing of my echoes and doctor’s visits. This created gaps in treatment. Once my refills became consistent and those delays stopped, the treatment began working much better.


Time pointCamzyos statusEjection fractionLVOT gradient at restLVOT gradient with Valsalva / provocationMitral valve / SAM notesWhat changed
Apr. 2021Before Camzyos65-70%90 mmHg94 mmHgSystolic anterior motion (SAM); mild-to-moderate mitral regurgitationHistorical severe obstruction
Aug. 2024Before Camzyos60-65%27 mmHg51 mmHgSAM; moderate mitral regurgitationStill obstructive, though less severe than 2021
May 2025Before starting Camzyos protocol50-55%65 mmHg100 mmHgSAM; mild mitral regurgitationStrong pre-treatment baseline: significant obstruction
Jul. 2025Early Camzyos follow-up60-65%Not listed in summary57 mmHgTrace mitral regurgitationEarly improvement from the May 2025 provoked gradient
Aug.-Nov. 2025On Camzyos, still being adjusted/monitored60-65% where listedVaried; one report listed 39 mmHgVaried, including 84-145 mmHg in follow-up echoesMitral regurgitation generally mild or not significant in these reportsImprovement was not a perfectly straight line
Jan. 2026On Camzyos60-65%10 mmHg24 mmHgNo major valve issue highlighted in the summaryObstruction was much lower than the May 2025 baseline
Jun. 2026On Camzyos, latest echo55-60%3 mmHg8 mmHgMild SAM noted, but “no outflow obstruction”; mild mitral regurgitationBest documented result in this set: very low gradients

So yes, I am in a much better place. My heart is working with far less obstruction than it has in years. Between Camzyos and taking Metoprolol ER 200 mg twice daily, I am cautiously optimistic that I can remain on this path.

These results do not mean that my hypertrophic cardiomyopathy is gone, but they do show that the treatment is doing what it is supposed to do. After years of seeing much higher numbers, I am grateful to finally be able to share some genuinely encouraging news.

#faith #health #personal

 
Read more... Discuss...

Join the writers on Write.as.

Start writing or create a blog